pH-Responsive Resveratrol Liposomes Targeting Sigma1 Receptor Attenuate Renal Fibrosis by Remodeling the Renal Microenvironment
Molecular Pharmaceutics · 02.03.2026 · 23 (3) · 1647-1666
DOI: 10.1021/acs.molpharmaceut.5c01381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 09.02.2026. Verfasst von Ning Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian 116029, China. Hauptthemen laut MEDLINE: Receptors, sigma, Resveratrol, Liposomes, Kidney. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Natural Science Foundation of Liaoning Province, Special funds for basic scientific research business expenses of undergraduate universities in Liaoning Province.
Abstract (Originalsprache)
Renal fibrosis (RF), a critical pathogenic mechanism in chronic kidney disease (CKD), now has exceedingly few therapeutic alternatives. This study presents a new sigma1 receptor (σ1R)-targeted nanodelivery system utilizing the natural polyphenolic medicine resveratrol (Res) as a therapeutic agent, addressing its low bioavailability and inadequate targeting properties, thereby providing a significant advancement in the treatment of RF. We engineered and produced a multifunctional material, aminoethyl anisamide-poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate (APC)-with benefits including active targeting, prolonged circulation, and pH sensitivity. In vitro investigations demonstrated that in the high glucose-induced HK-2 cell fibrosis model, the absorption efficiency of APC-modified liposomes was markedly enhanced, effectively suppressing the expression of fibrotic and inflammatory factors. In two typical animal models of RF, namely diabetic nephropathy and glomerulonephritis, APC@Res demonstrated therapeutic advantages, including modulation of the TGF-β1/Smad3 signaling pathway to impede fibrosis, a notable reduction in oxidative stress levels, enhanced renal function parameters, and diminished expression of inflammatory and fibrotic markers. This study innovatively employs the renal microacidic environment and sigma1 targeting to develop an effective delivery system, offering a novel treatment strategy for reversing RF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian 116029, China.
- College of Life Science, Liaoning Normal University, Dalian 116029, China.
ORCID-Profile: Huan Xu
Förderung
- Natural Science Foundation of Liaoning Province
- Special funds for basic scientific research business expenses of undergraduate universities in Liaoning Province
Zitieren
APA
Yang, N., Song, Y., Song, J., Qin, J., Fu, M., Yao, F., & Xu, H. (2026). pH-Responsive Resveratrol Liposomes Targeting Sigma1 Receptor Attenuate Renal Fibrosis by Remodeling the Renal Microenvironment. Molecular Pharmaceutics, 23(3), 1647-1666. https://doi.org/10.1021/acs.molpharmaceut.5c01381
Vancouver
Yang N, Song Y, Song J, Qin J, Fu M, Yao F, et al. pH-Responsive Resveratrol Liposomes Targeting Sigma1 Receptor Attenuate Renal Fibrosis by Remodeling the Renal Microenvironment. Molecular Pharmaceutics. 2026;23(3):1647-1666. doi:10.1021/acs.molpharmaceut.5c01381
BibTeX
@article{Yang2026,
author = {Yang, Ning and Song, Yule and Song, Junliang and Qin, Jian and Fu, Mingwei and Yao, Feng and Xu, Huan},
title = {pH-Responsive Resveratrol Liposomes Targeting Sigma1 Receptor Attenuate Renal Fibrosis by Remodeling the Renal Microenvironment},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {3},
pages = {1647--1666},
doi = {10.1021/acs.molpharmaceut.5c01381}
}
EUVIMED